FA
NUVA

Friess Associates’s NuVasive, Inc. NUVA Stock Holding History

Friess Associates’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-161,705
Closed -$12.5M – 149
2019
Q4 		$12.5M Sell
161,705
-93,636
-37% -$6.61M 0.87% 52
2019
Q3 		$16.2M Buy
+255,341
New +$16M 1.25% 45
2015
Q3 		– Sell
-213,175
Closed -$10.1M – 182
2015
Q2 		$10.1M Buy
213,175
+31,800
+18% +$1.49M 0.84% 56
2015
Q1 		$8.34M Sell
181,375
-8,325
-4% -$387K 0.67% 64
2014
Q4 		$8.95M Buy
189,700
+43,000
+29% +$1.79M 0.72% 57
2014
Q3 		$5.12M Buy
+146,700
New +$5.22M 0.44% 68

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Friess Associates's NUVA Position: Q1 2020 in Review

Friess Associates sold out of NuVasive, Inc. (NUVA) in Q1 2020, closing a stake of 161,705 shares — an estimated $12.5M sold.

Friess Associates first reported a position in NUVA in Q3 2014 and held it in 6 quarters. The position peaked at $16.2M in Q3 2019. 266 funds tracked by Wall St. Rank hold NUVA as of Q1 2020.

  • Friess Associates reported no remaining NuVasive, Inc. position as of Q1 2020 after selling out during the quarter.
  • Friess Associates sold 161,705 NuVasive, Inc. shares in Q1 2020, an estimated $12.5M.
  • Friess Associates first reported a position in NuVasive, Inc. in Q3 2014 and held it in 6 quarters.
  • Friess Associates's NuVasive, Inc. position peaked at $16.2M in Q3 2019.
  • 266 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2020.

Based on Friess Associates's 13F filing for Q1 2020, filed 15 May 2020.